Artemis MED Service Ltd
NSE: ARTEMISMED · Hospital · sector
₹287.20NSE close 2026-10-26
Key numbers
Market cap₹4,547 cr
Price₹287.20
52w high / low₹379 / ₹203
P/E39.9xSector median 42.5x
P/B4.9xSector median 4.9x
Book value₹59.0
Dividend yield0.13%Sector median 0.17%
ROE12.8%Sector median 12.1%
ROCE15.4%Sector median 13.8%
OPM18.0%Sector median 20.3%
Debt / equity0.24xSector median 0.24x
EV/EBITDA22.8xSector median 23.6x
Interest cover6.7x
Current ratio1.74x
Sales growth 3y+13.6%Sector median +14.1%
Profit growth 3y+42.4%Sector median +14.7%
PEG1.27x
Last 12 months to Jun 2026, Consolidated. "Sector median" = middle value of 32 companies in Hospital (P/E median leaves out loss-making companies). Tap ? for what a number means.
Things to know
- Cash ₹206 cr vs borrowings ₹227 cr (FY26): borrowings are higher by ₹21 cr.
- Operating profit covered interest 6.7x in the last 12 months.
- No promoter shares are pledged.
- Promoter holding fell by 8.14 percentage points in a year, to 58.39% (2026-09-30).
- Operating cash flow was below net profit in 0 of the last 5 years.
- Revenue was higher than a year earlier in 4 of the last 4 quarters.
- Other income was 25% of net profit in the last 12 months.
- Dividend paid in 3 of the last 5 financial years.
- Price ₹287.20 on 2026-10-26: -24.2% from the 52-week high, +41.2% from the 52-week low.
Plain facts from the filings, built by the same fixed rules for every company. A line appears only when the data for it is available. Not a view on the stock.
Charts
Weekly close · high ₹354.30 · low ₹217.33
RevenueNet profit
RevenueNet profit
Quarterly results
| ₹ cr | Sep 2024 | Dec 2024 | Mar 2025 | Jun 2025 | Sep 2025 | Dec 2025 | Mar 2026 | Jun 2026 |
|---|---|---|---|---|---|---|---|---|
| Revenue | 241 | 232 | 240 | 255 | 275 | 272 | 279 | 287 |
| EBITDA | 42 | 37 | 36 | 41 | 51 | 41 | 52 | 56 |
| OPM % | 17.5% | 16.1% | 15.0% | 16.2% | 18.4% | 15.2% | 18.5% | 19.6% |
| Other income | 7 | 9 | 12 | 7 | 8 | 7 | 8 | 5 |
| Net profit | 22 | 21 | 23 | 21 | 30 | 22 | 30 | 31 |
| EPS (₹) | 1.42 | 1.32 | 1.47 | 1.35 | 1.90 | 1.41 | 1.90 | 1.98 |
| Revenue YoY | +13.8% | +17.2% | +16.4% | +12.7% | ||||
| Profit YoY | +34.6% | +8.1% | +30.4% | +47.1% |
Consolidated figures where filed. Latest quarter Jun 2026.
Profit & loss (yearly)
| ₹ cr | FY22 | FY23 | FY24 | FY25 | FY26 | TTM |
|---|---|---|---|---|---|---|
| Revenue | 555 | 737 | 879 | 937 | 1,081 | 1,114 |
| EBITDA | 67 | 94 | 133 | 152 | 185 | 200 |
| Net profit | 32 | 36 | 49 | 83 | 104 | 114 |
| EPS (₹) | 2.40 | 2.89 | 3.62 | 5.37 | 6.56 | 7.19 |
| Revenue growth | +32.9% | +19.1% | +6.6% | +15.4% | +15.0% | |
| Profit growth | +12.9% | +36.9% | +68.2% | +25.4% | +30.3% | |
| Dividend / share (₹) | – | – | 0.45 | 0.45 | 0.45 |
| Compounded growth | 3 years | 5 years | Last 12 months |
|---|---|---|---|
| Sales | +13.6% | +21.5% | +15.0% |
| Net profit | +42.4% | +75.9% | +30.3% |
| EPS | +31.4% | +6.0% | – |
| Share price | – | +4.4% (2y) | +24.6% |
Balance sheet
| ₹ cr | FY22 | FY23 | FY24 | FY25 | FY26 |
|---|---|---|---|---|---|
| Shareholders' equity | – | 403 | 448 | 838 | 935 |
| Borrowings | – | 242 | 254 | 246 | 227 |
| Cash & equivalents | – | 51 | 61 | 396 | 206 |
| Total assets | – | 905 | 972 | 1,357 | 1,429 |
| Fixed assets | – | 516 | 610 | 655 | 721 |
| Capital work in progress | – | 95 | 33 | 39 | 28 |
| Investments | – | 0 | 0 | 0 | 0 |
| Receivables | – | 93 | 95 | 101 | 120 |
| Inventory | – | 14 | 10 | 10 | 13 |
| Payables | – | 88 | 95 | 101 | 98 |
Year-end figures from the March annual filing.
Cash flow
| ₹ cr | FY22 | FY23 | FY24 | FY25 | FY26 |
|---|---|---|---|---|---|
| Cash from operations | 60 | 127 | 109 | 146 | 132 |
| Cash from investing | -107 | -158 | -87 | -385 | -90 |
| Cash from financing | 44 | 38 | -30 | 267 | -50 |
| Capex | 109 | 146 | 73 | 93 | 105 |
| Free cash flow | -49 | -19 | 36 | 52 | 27 |
Free cash flow = cash from operations − capex.
Ratios by year
| ₹ cr | FY22 | FY23 | FY24 | FY25 | FY26 |
|---|---|---|---|---|---|
| ROE % | – | 8.9% | 11.0% | 9.9% | 11.1% |
| ROCE % | – | 10.9% | 14.2% | 12.9% | 14.4% |
| Debtor days | – | 46 | 39 | 39 | 40 |
| Inventory days | – | 26 | 17 | 16 | 19 |
| Payable days | – | 165 | 158 | 162 | 142 |
| Cash conversion cycle (days) | – | -93 | -102 | -107 | -83 |
| Working capital days | – | -18 | -2 | 126 | 53 |
Shareholding
| Holder | % (2026-09-30) |
|---|---|
| Promoters | 58.39% |
| FIIs | 12.46% |
| DIIs | 1.91% |
| of which Mutual funds | 0.92% |
| Government | 6.16% |
| Public (non-institutions) | 21.08% |
| Quarter | Mar 2025 | Jun 2025 | Sep 2025 | Nov 2025 | Dec 2025 | Mar 2026 | Jun 2026 | Sep 2026 |
|---|---|---|---|---|---|---|---|---|
| Promoters % | 67.17% | 66.53% | 66.53% | 58.43% | 58.39% | 58.39% | 58.39% | 58.39% |
| Promoter group | % |
|---|---|
| Constructive Finance Private Limited | 58.38% |
| Kerala State Industrial Development Corporation | 1.90% |
| Onkar Kanwar | 0.01% |
| Taru Kanwar | 0.00% |
| Raaja Kanwar | 0.00% |
| Sunrays Properties and Investments Company Private Limited | 0.00% |
| Landmark Farms and Housing Private Limited | 0.00% |
| Milers Global Pvt Ltd | 0.00% |
| Classic Industries and Exports Limited | 0.00% |
| PTL Enterprises Limited | 0.00% |
| OSK Holdings Private Limited | 0.00% |
| Apollo Tyres Limited | 0.00% |
| Polar Energy and Infratech Private Limited | 0.00% |
| Fortune Propmart Private Limited | 0.00% |
| Leto Realtors Private Limited | 0.00% |
| Public holders above 1% | % |
|---|---|
| International Finance Corporation | 11.98% |
| Governor of Kerala | 4.26% |
| Devlina Chakravarty | 2.84% |
| Artemis Medicare Services Limited-unclaimed Suspense Account | 1.48% |
44,260 shareholders. Pledged: 0.00% of promoter shares.
Peers in Hospital
| Company | Market cap | P/E | P/B | ROE | ROCE | OPM | Sales 3y | Div yield |
|---|---|---|---|---|---|---|---|---|
| APOLLOHOSP | ₹1,12,797 cr | 54.0x | 11.9x | 23.6% | 21.8% | 15.1% | +14.9% | 0.26% |
| MAXHEALTH | ₹81,266 cr | 55.7x | 7.6x | 14.5% | 13.8% | 26.1% | +22.4% | 0.18% |
| MANIPALHOS | ₹73,581 cr | – | – | – | – | – | – | – |
| FORTIS | ₹55,467 cr | 52.9x | 5.6x | 11.1% | 13.2% | 22.2% | +13.2% | 0.14% |
| NH | ₹33,971 cr | 41.4x | 7.5x | 20.0% | 13.7% | 18.7% | +20.4% | 0.26% |
| ASTERDM | ₹33,523 cr | 104.7x | 7.3x | 8.0% | 12.8% | 16.7% | -27.0% | 0.16% |
| MEDANTA | ₹32,575 cr | 58.5x | 8.2x | 15.1% | 15.8% | 20.5% | +17.9% | 0.04% |
| KIMS | ₹28,123 cr | 131.3x | 12.5x | 9.3% | 9.6% | 19.5% | +21.1% | 0.74% |
| AGARWALEYE | ₹15,065 cr | 101.3x | 7.4x | 7.6% | 16.5% | 27.8% | – | 0.01% |
| ARTEMISMED | ₹4,547 cr | 39.9x | 4.9x | 12.8% | 15.4% | 18.0% | +13.6% | 0.13% |
Dividends & corporate actions
| Ex-date | Action | Detail |
|---|---|---|
| 2026-07-10 | Dividend | Dividend - Re 0.45 Per Share |
| 2025-07-11 | Dividend | Dividend - Re 0.45 Per Share |
| 2024-07-05 | Dividend | Dividend - Rs 0.45 Per Share |
| 2023-07-14 | Dividend | Dividend - Re 0.45 Per Share |
| 2021-09-23 | Split | Face Value Split (Sub-Division) - From Rs 10/- Per Share To Re 1/- Per Share |
| 2021-07-12 | Other | Annual General Meeting |
| 2020-09-15 | Other | Annual General Meeting |
Documents
- Annual report FY26
- Annual report FY25
- Annual report FY24
- Annual report FY23
- Annual report FY22
- Announcements NSE filings
- BRSR FY26
- Latest results (data file) XBRL
- Announcements BSE filings
Links go to the original files on the exchange website.
About the company
- Healthcare Services: Multi-speciality Medical Services
| Sector | Healthcare |
| Industry | Hospital |
| Sub-industry | Hospital |
| Symbol | ARTEMISMED |
| BSE code | 542919 |
| ISIN | INE025R01021 |
| Face value | ₹1.0 |
| Incorporated | 2004-05-18 |
| Website | www.artemishospitals.com |
| Plants (India / abroad) | 3 / 0 |
From the company's filings (BRSR FY26).
Data built 2026-10-23 from NSE company filings (XBRL: Integrated Filing - Financials + financial results), NSE shareholding & pledge data; price = NSE close 2026-10-26.